Shakun Malik

Shakun Malik, MD

Head, Thoracic Cancer Therapeutics, Cancer Therapy Evaluation Program, National Cancer Institute

Latest Stories
FreeGuest Editorial
S2302 Pragmatica-Lung is a federally-funded, streamlined clinical trial examining a new combination of agents in patients with advanced non-small cell lung cancer (NSCLC). Like most studies, it is focused on improving outcomes for patients with cancer—but it is also poised to simplify and transform the entire clinical trials model as we know it. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login